Novel bacteriophage having ability to specifically kill clostridium perfringens and antibacterial composition comprising the same
US-2024150725-A1 · May 9, 2024 · US
This patent family groups 1 related publication across US. Members often share priority claims or equivalent filings in different countries.
| Field | Value |
|---|---|
| Family ID | 83048278 |
| Family type | — |
| Earliest priority | Feb 25, 2021 |
| First filing country | US |
| Member publications | 1 |
| Countries | US |
| Representative publication | US2024150725A1 — Novel bacteriophage having ability to specifically kill clostridium perfringens and antibacterial composition comprising the same |
Best representative member for this family based on priority and filing country.
US2024150725A1 — Novel bacteriophage having ability to specifically kill clostridium perfringens and antibacterial composition comprising the same (published May 9, 2024)
Related publications in this family.